Literature DB >> 16646592

Cardiac ischemia and uncoupling: gap junctions in ischemia and infarction.

Stefan Dhein1.   

Abstract

Acute cardiac ischemia is often associated with ventricular arrhythmia and fibrillation. Due to the loss of ATP, the depolarization of the fibers, and the intracellular Na(+) and Ca(2+) overload with concomitant acidification as well as the accumulation of lysophosphoglyceride and arachidonic acid metabolites, propagation of action potentials will be impaired by two factors: (a) reduced sodium channel availability and (b) gap junction uncoupling. While gap junction uncoupling leads to predominant transverse uncoupling, reduced I (Na) availability results in impaired longitudinal conduction. Complete gap junction uncoupling would initiate arrhythmia, while intermediate uncoupling has been shown to enhance the safety factor (SF) of propagation, limiting the current loss to non-depolarized areas. In contrast, a reduction in I(Na) availability reduces SF, and partial gap junction uncoupling might enable effective but slow conduction which, on the other hand, could form the basis for some kind of reentrant arrhythmia, paving the way for new anti-arrhythmic approaches in gap junction coupling. In the chronic phase, remodeling processes also involve gap junctions and lead to highly heterogeneous non-uniform tissue which may serve as an arrhythmogenic trigger.

Entities:  

Mesh:

Year:  2006        PMID: 16646592     DOI: 10.1159/000092570

Source DB:  PubMed          Journal:  Adv Cardiol        ISSN: 0065-2326


  16 in total

1.  Generation and escape of local waves from the boundary of uncoupled cardiac tissue.

Authors:  Vadim N Biktashev; Ara Arutunyan; Narine A Sarvazyan
Journal:  Biophys J       Date:  2008-01-22       Impact factor: 4.033

Review 2.  Pharmacological modulation of connexin-formed channels in cardiac pathophysiology.

Authors:  Elke De Vuyst; Kerstin Boengler; Gudrun Antoons; Karin R Sipido; Rainer Schulz; Luc Leybaert
Journal:  Br J Pharmacol       Date:  2011-06       Impact factor: 8.739

Review 3.  Adrenergic control of cardiac gap junction function and expression.

Authors:  Aida Salameh; Stefan Dhein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-02-12       Impact factor: 3.000

Review 4.  Connexin 43 is an emerging therapeutic target in ischemia/reperfusion injury, cardioprotection and neuroprotection.

Authors:  Rainer Schulz; Philipp Maximilian Görge; Anikó Görbe; Péter Ferdinandy; Paul D Lampe; Luc Leybaert
Journal:  Pharmacol Ther       Date:  2015-06-11       Impact factor: 12.310

Review 5.  Connexins in Cardiovascular and Neurovascular Health and Disease: Pharmacological Implications.

Authors:  Luc Leybaert; Paul D Lampe; Stefan Dhein; Brenda R Kwak; Peter Ferdinandy; Eric C Beyer; Dale W Laird; Christian C Naus; Colin R Green; Rainer Schulz
Journal:  Pharmacol Rev       Date:  2017-10       Impact factor: 25.468

Review 6.  Ventricular fibrillation and defibrillation.

Authors:  P Jones; N Lodé
Journal:  Arch Dis Child       Date:  2007-10       Impact factor: 3.791

7.  Local effects and mechanisms of antiarrhythmic peptide AAP10 in acute regional myocardial ischemia: electrophysiological and molecular findings.

Authors:  Joanna Jozwiak; Stefan Dhein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-06-24       Impact factor: 3.000

8.  Sex-dependent gene regulatory networks of the heart rhythm.

Authors:  D A Iacobas; S Iacobas; N Thomas; D C Spray
Journal:  Funct Integr Genomics       Date:  2009-09-16       Impact factor: 3.410

9.  Bax Inhibitor-1 Is a pH-dependent regulator of Ca2+ channel activity in the endoplasmic reticulum.

Authors:  Hyung-Ryong Kim; Geum-Hwa Lee; Ki-Chan Ha; Taeho Ahn; Ji-Yong Moon; Bong-Jin Lee; Ssang-Goo Cho; Sanguk Kim; Young-Rok Seo; Yong-Joo Shin; Soo-Wan Chae; John C Reed; Han-Jung Chae
Journal:  J Biol Chem       Date:  2008-03-31       Impact factor: 5.157

10.  Characterization of the structure and intermolecular interactions between the connexin40 and connexin43 carboxyl-terminal and cytoplasmic loop domains.

Authors:  Denis Bouvier; Gaelle Spagnol; Sylvie Chenavas; Fabien Kieken; Heidi Vitrac; Sarah Brownell; Admir Kellezi; Vincent Forge; Paul L Sorgen
Journal:  J Biol Chem       Date:  2009-10-05       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.